/
/
Syntese og karakterisering av Placental Chondroitin Sulfate en (plCSA) - målretting Lipid - Polymer nanopartikler
Un abonnement à JoVE est nécessaire pour voir ce contenu. Connectez-vous ou commencez votre essai gratuit.
1Laboratory for Reproductive Health, Institute of Biomedicine and Biotechnology,Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences (CAS), 2Guangdong Key Laboratory of Nanomedicine, CAS Key Lab for Health Informatics,Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences (CAS), 3Department of Chemistry,Guangdong Medical University
Chapitres
- 00:04Titre
- 00:35Synthesis of DNPs
- 01:34Conjugation of Peptides to DNPs
- 02:54Fluorescence Microscopy Assessment of pICSA-Targeted Nanoparticle Uptake in Choriocarcinoma (JEG3) Cells
- 04:18Results: Characterization and Cellular Uptake of plCSA-DNPs
- 05:12Conclusion
Her presenterer vi en protokoll for syntese av placental chondroitin sulfate A bindende peptid (plCSA-BP)-konjugert lipid-polymer nanopartikler via enkeltsteg sonication og bioconjugate teknikker. Disse partiklene utgjør et romanen verktøy for målrettet levering av therapeutics til de fleste mennesker svulster og placental trophoblasts til å behandle kreft og placental lidelser.
